Point of Care Technologies - Diagnostics

Share:

EmailFacebookLinkedInXWhatsAppShare
This program supports the technology development of rapid in-vitro diagnostic technologies and monitoring platforms that provide real time medical evaluation and analysis of the disease status or condition at the time and place of patient care.

Emphasis

The program includes the delivery of healthcare that is safe, effective, timely, patient-centered, efficient, and available in centralized and decentralized locations. The emphasis is on developing technologies driven by clinical needs. Examples of technology development areas in this program include but are not limited to disposable lateral flow assays, nucleic acid testing platforms, glucose monitoring devices, etc.

Program priorities

  • Rapid: ideal diagnostic test time to identify species and determine drug susceptibility profiles, process the clinical sample (if appropriate), and detection and delivery of the final test result during a single interaction
  • Sensitive: sensitivity should be equivalent to or exceed current standards for proposed targets from the same sample type
  • Specific: specificity should be equivalent to or exceed current standards for proposed targets from the same sample type
  • Easy-to-use: integrated, closed sample-to-answer system with automated data analyses and/or result presentation and with minimal operator training and expertise required
  • Cost-effective: projected production and operating costs should be consistent or an improvement on commonly used platforms

Featured programs and resources

Point of Care Technology Research Network

NIBIB created the Point-of-Care Technologies Research Network (POCTRN) to drive the development of appropriate point-of-care diagnostic technologies through collaborative efforts that merge scientific and technological capabilities with clinical need. Today, with the support of the National Heart, Lung and Blood Institution, National Institute of Allergy and Infectious Diseases, National Center for Complementary and Integrative Health, Fogarty International Center, Office of Behavioral and Social Sciences Research, Office of AIDS Research and Office of Disease Prevention, the following Centers comprise POCTRN.

  • Point of Care Technology Research Network Center- Coordinating Center
  • Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
  • The Center for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern (C-THAN)
  • Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME-POCT)
  • The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases

Visit www.poctrn.org for detailed information.

Point of Care Technology listserv

The e-newsletter serves as an information outlet to the Point of Care Technology community on current activities and initiatives involving point of care technology research supported by the National Institutes of Health. Join the NIBIB Point of Care Technologies listserv.

Notice of Special Interest in Physiological Monitoring and Point of Care Technologies for Trauma Care

    Related News

    November 16, 2023

    Within one year of launching its incubator hubs, the National Institutes of Health Blueprint MedTech program has issued nine awards in its first competition cycle. The MedTech program seeks to

    September 21, 2023
    NIH will advance the development of home-based and point-of-care health technologies with awards to six technology research and development centers around the country. The centers comprise the Point of Care Technology Research Network (POCTRN) and will parlay the momentum of the original network established in 2007 by the NIBIB.
    July 24, 2023
    New recommendations from the NIH Rapid Acceleration of Diagnostics (RADx®) Tech Program provide a blueprint for the design and manufacture of more accessible diagnostic tests.
    June 8, 2023
    In Late January 2023, NIBIB launched a new center designed to accelerate biomedical discovery and therapeutics, in part by pulling together expert, multidisciplinary teams from throughout NIH to quickly respond when national or global health crises strike. Source: IEEE Pulse
    June 2, 2023
    An image of a thyroid tumor, produced by high-definition microvasculature imaging, shows the tumor's microvasculature in high detail.
    Researchers have shown that an automated cancer diagnostic method, which pairs cutting-edge ultrasound techniques with artificial intelligence, can accurately diagnose thyroid cancer, of which there are more than 40,000 new cases every year.